Your browser doesn't support javascript.
loading
Increased Cardiac Risk After a Second Malignant Neoplasm Among Childhood Cancer Survivors: A FCCSS Study.
Charrier, Thibaud; Haddy, Nadia; Schwartz, Boris; Journy, Neige; Fresneau, Brice; Demoor-Goldschmidt, Charlotte; Diallo, Ibrahima; Surun, Aurore; Aerts, Isabelle; Doz, François; Souchard, Vincent; Vu-Bezin, Giao; Laprie, Anne; Lemler, Sarah; Letort, Véronique; Rubino, Carole; Chounta, Stéfania; de Vathaire, Florent; Latouche, Aurélien; Allodji, Rodrigue S.
Afiliação
  • Charrier T; Cancer and Radiation Team, Centre de Research en Epidemiologie et Santé des Populations, Université Paris-Saclay- Université Paris-Sud-Université de Versailles Saint-Quentin-en-Yvelines, Villejuif, France.
  • Haddy N; Cancer and Radiation Team, Centre de Research en Epidemiologie et Santé des Populations, Institut National de la Santé et de la Recherche Médicale, Villejuif, France.
  • Schwartz B; Cancer and Radiation Team, Department of Clinical Research, Gustave Roussy, Villejuif, France.
  • Journy N; U900, Institut National de la Santé et de la Recherche Médicale, PSL Research University, Institut Curie, Saint-Cloud, France.
  • Fresneau B; Cancer and Radiation Team, Centre de Research en Epidemiologie et Santé des Populations, Université Paris-Saclay- Université Paris-Sud-Université de Versailles Saint-Quentin-en-Yvelines, Villejuif, France.
  • Demoor-Goldschmidt C; Cancer and Radiation Team, Centre de Research en Epidemiologie et Santé des Populations, Institut National de la Santé et de la Recherche Médicale, Villejuif, France.
  • Diallo I; Cancer and Radiation Team, Department of Clinical Research, Gustave Roussy, Villejuif, France.
  • Surun A; Cancer and Radiation Team, Centre de Research en Epidemiologie et Santé des Populations, Université Paris-Saclay- Université Paris-Sud-Université de Versailles Saint-Quentin-en-Yvelines, Villejuif, France.
  • Aerts I; Cancer and Radiation Team, Centre de Research en Epidemiologie et Santé des Populations, Institut National de la Santé et de la Recherche Médicale, Villejuif, France.
  • Doz F; Cancer and Radiation Team, Department of Clinical Research, Gustave Roussy, Villejuif, France.
  • Souchard V; Cancer and Radiation Team, Centre de Research en Epidemiologie et Santé des Populations, Université Paris-Saclay- Université Paris-Sud-Université de Versailles Saint-Quentin-en-Yvelines, Villejuif, France.
  • Vu-Bezin G; Cancer and Radiation Team, Centre de Research en Epidemiologie et Santé des Populations, Institut National de la Santé et de la Recherche Médicale, Villejuif, France.
  • Laprie A; Cancer and Radiation Team, Department of Clinical Research, Gustave Roussy, Villejuif, France.
  • Lemler S; Cancer and Radiation Team, Centre de Research en Epidemiologie et Santé des Populations, Université Paris-Saclay- Université Paris-Sud-Université de Versailles Saint-Quentin-en-Yvelines, Villejuif, France.
  • Letort V; Department of Pediatric Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
  • Rubino C; Cancer and Radiation Team, Centre de Research en Epidemiologie et Santé des Populations, Institut National de la Santé et de la Recherche Médicale, Villejuif, France.
  • Chounta S; Cancer and Radiation Team, Department of Clinical Research, Gustave Roussy, Villejuif, France.
  • de Vathaire F; Department of Pediatric Oncology, Centre Hospitalier Universitaire, Angers, France.
  • Latouche A; Department of Radiotherapy, Centre François Baclesse, Caen, France.
  • Allodji RS; Department of Supportive Care, Centre François Baclesse, Caen, France.
JACC CardioOncol ; 5(6): 792-803, 2023 Dec.
Article em En | MEDLINE | ID: mdl-38205003
ABSTRACT

Background:

Childhood cancer survivors (CCS) are at an elevated risk of developing both a second malignant neoplasm (SMN) and cardiac disease.

Objectives:

This study sought to assess the excess of occurrence of cardiac disease after a SMN among CCS.

Methods:

Analyses included 7,670 CCS from the French Childhood Cancer Survivors Study cohort diagnosed between 1945 and 2000. To account for the time dependence of the occurrence of a SMN, we employed a landmark approach, considering an additive regression model for the cumulative incidence of cardiac disease. We estimated the effect of a SMN on the instantaneous risk of cardiac disease using a proportional cause-specific hazard model, considering a SMN as a time-dependent exposure. In both models, we adjusted for demographic and treatment information and considered death as a competing event.

Results:

In 7,670 CCS over a median follow-up of 30 years (IQR 22-38 years), there were 378 cases of cardiac disease identified, of which 49 patients experienced a SMN. Patients who survived 25 years after their childhood cancer diagnosis and had a SMN in that time frame had a significantly increased cumulative incidence of cardiac disease, which was 3.8% (95% CI 0.5% to 7.1%) higher compared with those without a SMN during this period. No SMN-induced excess of cardiac disease was observed at subsequent landmark times. SMNs were associated with a 2-fold increase (cause-specific HR 2.0; 95% CI 1.4-2.8) of cardiac disease.

Conclusions:

The occurrence of a SMN among CCS is associated with an increased risk of cardiac disease occurrence and risk at younger ages.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Risk_factors_studies Idioma: En Revista: JACC CardioOncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Risk_factors_studies Idioma: En Revista: JACC CardioOncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França